Development and testing of the patient-reported chemotherapy indicators of symptoms and experience: patient-reported outcome and process indicators sensitive to the quality of nursing care in ambulatory chemotherapy settings
Development and testing of the patient-reported chemotherapy indicators of symptoms and experience: patient-reported outcome and process indicators sensitive to the quality of nursing care in ambulatory chemotherapy settings
BACKGROUND: Outcome indicators are increasingly advocated to demonstrate the impact of high-quality care; however, generic measures do not encompass outcomes relevant to specialist areas.
OBJECTIVE: The aim of this study was to develop an outcome measure (Patient-Reported Chemotherapy Indicators of Symptoms and Experience [PR-CISE]) for use in ambulatory chemotherapy settings and assess its feasibility, acceptability, and preliminary efficacy in clinical practice.
METHODS: Three areas were covered by PR-CISE-symptom management, safe medication administration, and experience of supportive care. Outcome selection was guided by review of evidence and reference groups of users, clinicians, and experts. Over 12 weeks, PR-CISE was distributed to patients receiving ambulatory chemotherapy at 10 cancer centers. Data were analyzed descriptively and with case mix adjustment using regression-based models.
RESULTS: There were 2466 responses. There was variability across centers in terms of symptom experience and support provided. Across the whole sample, 25% reported moderate or severe nausea; however, rates varied between centers (25%-75%). Similar results emerged for other symptoms. When asked about support for symptom management, 80% reported that chemotherapy nurses asked about and were aware of symptom severity and provided useful information/advice. Once again, there was substantial variability between centers. Unexplained variation remained after case mix adjustment, suggesting that differences may be "real" rather than caused by population differences. Stakeholders planned to make changes to care delivery based on data on their performance.
CONCLUSIONS: We successfully developed and tested indicators assessing the quality of care provided in ambulatory chemotherapy services.
IMPLICATIONS: Results show that monitoring outcomes demonstrate potential differences in care quality and provide a stimulus to improve the experience and health of patients.
Armes, J.
162c2c72-239b-425d-af92-77c0b5c7a432
Wagland, R.
16a44dcc-29cd-4797-9af2-41ef87f64d08
Finnegan-John, J.
cc86d6b3-e991-4a9b-ace4-73fbaad1fe06
Richardson, A.
3db30680-aa47-43a5-b54d-62d10ece17b7
Corner, J.
eddc9d69-aa12-4de5-8ab0-b20a6b5765fa
Griffiths, P.
ac7afec1-7d72-4b83-b016-3a43e245265b
17 October 2013
Armes, J.
162c2c72-239b-425d-af92-77c0b5c7a432
Wagland, R.
16a44dcc-29cd-4797-9af2-41ef87f64d08
Finnegan-John, J.
cc86d6b3-e991-4a9b-ace4-73fbaad1fe06
Richardson, A.
3db30680-aa47-43a5-b54d-62d10ece17b7
Corner, J.
eddc9d69-aa12-4de5-8ab0-b20a6b5765fa
Griffiths, P.
ac7afec1-7d72-4b83-b016-3a43e245265b
Armes, J., Wagland, R., Finnegan-John, J., Richardson, A., Corner, J. and Griffiths, P.
(2013)
Development and testing of the patient-reported chemotherapy indicators of symptoms and experience: patient-reported outcome and process indicators sensitive to the quality of nursing care in ambulatory chemotherapy settings.
Cancer Nursing, n/a.
(doi:10.1097/NCC.0b013e3182980420).
(PMID:24141376)
Abstract
BACKGROUND: Outcome indicators are increasingly advocated to demonstrate the impact of high-quality care; however, generic measures do not encompass outcomes relevant to specialist areas.
OBJECTIVE: The aim of this study was to develop an outcome measure (Patient-Reported Chemotherapy Indicators of Symptoms and Experience [PR-CISE]) for use in ambulatory chemotherapy settings and assess its feasibility, acceptability, and preliminary efficacy in clinical practice.
METHODS: Three areas were covered by PR-CISE-symptom management, safe medication administration, and experience of supportive care. Outcome selection was guided by review of evidence and reference groups of users, clinicians, and experts. Over 12 weeks, PR-CISE was distributed to patients receiving ambulatory chemotherapy at 10 cancer centers. Data were analyzed descriptively and with case mix adjustment using regression-based models.
RESULTS: There were 2466 responses. There was variability across centers in terms of symptom experience and support provided. Across the whole sample, 25% reported moderate or severe nausea; however, rates varied between centers (25%-75%). Similar results emerged for other symptoms. When asked about support for symptom management, 80% reported that chemotherapy nurses asked about and were aware of symptom severity and provided useful information/advice. Once again, there was substantial variability between centers. Unexplained variation remained after case mix adjustment, suggesting that differences may be "real" rather than caused by population differences. Stakeholders planned to make changes to care delivery based on data on their performance.
CONCLUSIONS: We successfully developed and tested indicators assessing the quality of care provided in ambulatory chemotherapy services.
IMPLICATIONS: Results show that monitoring outcomes demonstrate potential differences in care quality and provide a stimulus to improve the experience and health of patients.
Text
cancer nursing 2013 online early.pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: 17 October 2013
Organisations:
Faculty of Health Sciences
Identifiers
Local EPrints ID: 359442
URI: http://eprints.soton.ac.uk/id/eprint/359442
ISSN: 0162-220X
PURE UUID: 29dc8211-8be9-4e8c-9815-b8107c0104e2
Catalogue record
Date deposited: 04 Nov 2013 13:26
Last modified: 15 Mar 2024 03:37
Export record
Altmetrics
Contributors
Author:
J. Armes
Author:
J. Finnegan-John
Author:
J. Corner
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics